Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (2963)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
517
Price
$519.50
Total Value
$268.58K
Shares Held After
324,742
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,446
Price
$518.40
Total Value
$749.60K
Shares Held After
325,259
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,142
Price
$517.50
Total Value
$1.63M
Shares Held After
326,705
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,456
Price
$516.59
Total Value
$1.27M
Shares Held After
329,847
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
605
Price
$515.50
Total Value
$311.88K
Shares Held After
332,303
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
675
Price
$514.43
Total Value
$347.24K
Shares Held After
332,908
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
182
Price
$513.39
Total Value
$93.44K
Shares Held After
333,583
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
178
Price
$512.49
Total Value
$91.22K
Shares Held After
333,765
% of Holdings
0.1%
FATE THERAPEUTICS INC (FATE)
TAHL CINDY — Chief Legal and Compliance Officer
Shares
38,800
Price
$2.46
Total Value
$95.41K
Shares Held After
589,355
% of Holdings
6.2%
Korro Bio, Inc. (KRRO)
Aiyar Ram — Director
Shares
5,802
Price
$10.84
Total Value
$62.92K
Shares Held After
69,046
% of Holdings
7.8%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
800,000
Price
$0.50
Total Value
$400.00K
Shares Held After
883,886
% of Holdings
90.5%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
2,611
Price
$24.64
Total Value
$64.34K
Shares Held After
117,227
% of Holdings
2.2%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
1,500
Price
$23.87
Total Value
$35.80K
Shares Held After
119,838
% of Holdings
1.2%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,967
Price
$24.65
Total Value
$73.13K
Shares Held After
40,166
% of Holdings
6.9%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
1,794
Price
$23.89
Total Value
$42.86K
Shares Held After
43,133
% of Holdings
4.0%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
653
Price
$2.94
Total Value
$1.92K
Shares Held After
268,371
% of Holdings
0.2%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
653
Price
$2.95
Total Value
$1.92K
Shares Held After
328,737
% of Holdings
0.2%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
3,023
Price
$2.95
Total Value
$8.91K
Shares Held After
1,260,890
% of Holdings
0.2%
2963 transactions